GlassScriptPhysician profile
Claire Tichy
NPI 1275822140
$4,636.39
in general payments reported to CMS, 2019-2025
30 companies · $1,172 in 2025
The $1,172 reported for 2025 was more than what 87% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $656 · 2022: $1,176 · 2023: $779 · 2024: $854 · 2025: $1,172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,686 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,685.96 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $118.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $692.55 | 2022-2025 | Interstim |
| Sumitomo Pharma America, INC. | $636.70 | 2023-2025 | Orgovyx, Gemtesa |
| Coloplast Corp | $593.86 | 2021-2025 | Titan |
| Janssen Biotech, INC. | $523.38 | 2022-2025 | Erleada |
| Astellas Pharma US INC | $228.50 | 2021-2024 | Xtandi |
| Myovant Sciences INC. | $181.19 | 2022 | |
| Srs Medical Systems, INC. | $174.84 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $157.86 | 2022-2025 | |
| Olympus America INC. | $133.66 | 2022 | |
| Urovant Sciences INC | $133.07 | 2022 | |
| Ferring Pharmaceuticals INC. | $120.03 | 2024-2025 | Adstiladrin |
| 180 Medical, INC. | $116.20 | 2022 | |
| Boston Scientific Corporation | $103.92 | 2023-2025 | Axonics, Lithovue |
| Dendreon Pharmaceuticals LLC | $101.18 | 2023-2024 | Provenge |
| Merck Sharp & Dohme LLC | $100.54 | 2023-2024 | Keytruda, Welireg, Lynparza |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calyxo, INC. | $90.78 | 2024-2025 | Cvac Aspiration System |
| C. R. Bard, INC. & Subsidiaries | $86.22 | 2024-2025 | Magic3 Go Intermittent Urinary Catheter, Bard Urinary Drainage Bag |
| Endo Pharmaceuticals INC. | $82.97 | 2021-2023 | Xiaflex, Aveed |
| Pfizer INC. | $54.05 | 2024-2025 | |
| Procept Biorobotics Corporation | $46.06 | 2025 | |
| Myriad Genetic Laboratories, INC. | $44.82 | 2024-2025 | Prolaris |
| Smith+Nephew, INC. | $39.63 | 2025 | Stravix |
| Abbvie INC. | $32.09 | 2022-2024 | |
| Ambu INC. | $30.97 | 2021 | |
| Dentsply Ih Ab | $24.18 | 2025 | Lofric |
| Laborie Medical Technologies Corp. | $23.53 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Antares Pharma, INC. | $22.95 | 2024 | Xyosted |
| Axonics, INC. | $21.80 | 2023 | Axonics, Bulkamid |
| Amgen INC. | $21.23 | 2022 | |
| Becton, Dickinson and Company | $17.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claire Tichy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.